BULLETIN ON NARCOTICS - Volume VI, 1954
ABBREVIATIONS
NOTE
A
B
C
D
E
F
G
H
I
J
K
L
M
N
4 O
P
Q
R
S
T
U
V
W
X
Y
Pages: 1 to 6
Creation Date: 1955/01/01
ECOSOC |
stands for "Economic and Social Council" |
WHO |
stands for "World Health Organization" |
PCOB |
stands for "Permanent Central Opium Board" |
ICPC |
stands for "International Criminal Police Commission" |
References in italics indicate the beginning and the end of the article cited, when it deals, in its entirety, with the subject under which it is placed.
Acedicone hydrochloride
Physical data, No. 1, p. 12
X-ray diffraction data, No. 2, p. 46 (fig. No. 1, p. 60)
Acetic anhydride
Commission on Narcotic Drugs (9th session), No. 3-4, pp. 71, 72
Acetoxyketobemidone ydrochloride
Physical data, No. 1, p. 16
X-ray diffraction data, No. 2, p. 46 (fig. No. 2, p. 60)
Acetylmethadol, d-α- and dl, lmethadylacetate hydrochloride
Physical data, No. 1, p. 13
Acts see also: Laws
Act of 26 May 1922 (Narcotic Drugs Import and Export Act), No. 1, p. 2
Dangerous Drugs Act of 1930 (India), No. 3, p. 1
Decree of 19 November 1948 and drug addiction in France, No. 2, p. 13
Harrison Narcotic Law, No. 1, p. 2, 4, 5
Marihuana Tax Act, No. 1, p. 2
Opium Act of 1857, No. 3, p. 1
Opium Act of 1878 (India), No. 3, p. 1
Opium and Revenue Laws Act, 1950 (India), No. 3-4, p. 1Addiction
Bibliography, No. 1, p. 56, 57
Commission on Narcotic Drugs (9th session), No. 3-4, pp. 73, 74
Legislation (District of Columbia, U.S.A.), No. 2, pp. 70-71
Medical and social aspects in France, No. 2, p. 1-17
National Research Council, No. 1, p. 44
Some aspects of the social medical problem as seen by the general practitioner, No. 2, pp. 21-22
Traffic in narcotics, No. 1, pp. 1-6
Treatment, No. 1, p. 4; No. 2, p. 19
Treatment, care and rehabilitation, No. 2, pp. 18-20
Afghanistan
Use of heroin discontinued, No. 1, p. 42
All-India Narcotics Board
Production of opium, No. 3-4, p. 1
American Medical Association
Treatment of drug addiction, No. 2, p. 19
Analysis
Conformational, applied to morphine derivatives, No. 1, pp. 32-38
Methods of, No. 1, p. 89 of opium for morphine, No. 2, pp. 29 et seq.Anslinger, H.J.
Commission on Narcotic Drugs (9th session), No. 3-4, p. 71
The traffic in narcotics, No. 1, pp. 1-6 (photo)
Apomorphine hydrochloride
Identification, X-ray diffraction (fig., p. 60)
Physical data, No. 1, p. 12
X-ray diffraction data, No. 2, p.6
Argentina
Commission on Narcotic Drugs (9th session),
No. 3-4, pp. 71, 74
Heroin production, No. 1, p. 41
Assay
Opium for morphine, No. 2, p. 23 et seq.
Asthana, S.N.
Cultivation of the opium poppy in India, No. 3-4, pp 1-10
Australia
Heroin consumption, No. 1, p. 42
Heroin, Use of, discontinued, No. 1, p. 42
Barnes, W.H.
Physical methods for the identification of narcotics, Part II A, No. 1, p. 20-31; Part II B, No. 2, pp. 27-68
Belgium
Heroin production, No. 1, p. 41
Benzylmorphine hydrochloride
X-ray diffraction data, No. 2, p. 46 (figs. Nos. 4, 5, p. 60)
Bibliography
Identification of narcotics, No. 1, p. 19
Morphine, Conformational analysis of, No. 1, p. 38
Morphine, Isolation and determination of, No. 2, p. 26
Scientific publications on narcotic drugs for 1953, No. 1, pp. 48-57
Synthetic drugs, No. 2, pp. 73-83; No. 3-4, pp. 77-87
Ultraviolet spectrophotometry, No. 3-4, pp. 39-41, 70
X-ray diffraction powder method, No. 1, pp. 31, 37
Bolivia
Coca leaves, No. 1, p. 40
Commission on Narcotic Drugs (9th session), No. 3-4, pp. 71, 74
Bulgaria
Raw opium production, No. 1, p. 39
The traffic in narcotics, No. 1, p. 1
Bureau of Narcotics, U.S.A.
Duties, No. 1, p. 3
Post-war addiction, No. 1, p. 5
Burma
Commission on Narcotic Drugs (9th session), No. 3-4, p. 71
Cambodia
Opium, non-medical consumption, No. 1, p. 40
1953 Protocol, No. 2, p. 69
Campaign
Anti-narcotics, No. 1, p. 4
Canada
Committee of Chemical Experts, No. 3-4, pp. 72, 73
Committee on Seizures, No. 3-4, p. 72
Drug addiction, No. 2, pp. 7-9
1953 Protocol, No. 2, pp. 69, 70
Cannabis (Indian hemp)
Bibliography, No. 1, p. 53
Commission on Narcotic Drugs (9th session), No. 3-4, p. 74
Drug addiction in France, No. 2, p. 9
Expert Committee (WHO), No. 1, p. 47 Legislation in Tunisia, No. 2, pp. 71-72
New single convention, No. 1, p. 2
PCOB Report (1953), No. 1, pp. 40, 43
Ceylon
Opium import, No. 1, p. 40
Chile
1953 Protocol, No. 2, p. 69
China
Committee of Chemical Experts, No. 3-4, p. 73
Illicit traffic, No. 3-4, p. 72
1953 Protocol, No. 2, pp. 69, 70
Chirrah (or Agiya)
Disease of the poppy, No. 3-4, p. 10
Chromatography
Determination of morphine in opium, No. 2, pp. 23.-26
Clinic plan
Traffic of narcotics, No. 1, pp. 5, 6Clinics
Report on narcotic clinics, No. 2, p. 19
Coca leaves
Bibliography, No. 1, p. 53
Commission on Narcotic Drugs (9th session), No. 3-4, pp. 74, 75
Expert Committee (WHO), No. 1, pp. 46, 47
New single convention, No. 1, p. 2
Report of the PCOB, No. 1, p. 40
Cocaine, hydrochloride
Addiction, No. 1, p. 5
Bibliography, No. 1, p. 53
Crude cocaine, No. 1, p. 40
Drug addiction in France, No. 2, p. 9
Identification, X-ray diffraction, data No. 2, p. 47 (figs. Nos. 6, 7, p. 60)
Physical data, No. 1, pp. 12, 17
Codeine
Brought under control, No. 1, p. 41
Conformational analysis of morphine derivatives, No. 1, pp. 33 et seq.
Content in Indian opium, No. 3-4, pp. 8, 9
Conversion into morphine, No. 1, pp. 39, 44
Manufactured from morphine, No. 1, p. 40
Physical data, No. 1, p. 12
X-ray diffraction, No. 2, pp. 29, 30, 38, 40, 42, 43, 44, 45, 47 (figs. Nos. 8, 9, 10, 11, pp. 60, 61; Nos. 84, 85, 86, p. 68)
Codeinone, dihydro, and dihydrohydroxy
Physical data, No. 1, p. 12
Colombia
Coca leaves, No. 1, p. 40
Commission on Narcotic Drugs (9th session), No 3-4, pp. 71, 75
Commission on Narcotic Drugs
Ninth session, No. 3-4, pp. 71-75
Commissioner of Narcotics
Control of narcotics in the U.S.A., No. 1, pp. 2, 3
Committee of Chemical Experts
Commission on Narcotic Drugs (9th session), No. 34, pp. 72, 73
Committee on Seizures
Commission on Narcotic Drugs (9th session), No. 3-4, p. 72
Conferences
Shanghai
Traffic in narcotics, No. 1, p. 2
1931 Conference
Use of heroin, No. 1, pp. 41, 42
Congress, USA
Control of narcotics, No. 1, pp. 2, 3
Control
Opium in Pakistan, No. 3-4, pp. 11 et seq.
PCOB report for 1953, No. 1, pp. 39-43;No. 3-4, p. 71 et seq.
Twenty-five years' retrospect, No. 1, pp. 42, 43
1925 Convention (Action under)
Commission on Narcotic Drugs (9th session),
No. 3-4, pp. 71, 72
Heroin consumption, No. 1, p. 42
Report of PCOB (1953), No. 1, p. 39
Retrospect, No. 1, pp. 42-43
1951 Convention (Action under)
Commission on Narcotic Drugs (9th session), No. 3-4, pp. 71, 72
Dithienylbutenylamines, No. 1, p. 46
Drug addiction, No. 2, p. 18
N-allylnormorphine, No. 1, p. 45
Report of PCOB (1953), No. 1, pp. 39, 42
Synthetics of methadone type, No. 1, pp. 45, 46
Convention, New single
Commission on Narcotic Drugs (9th session), No. 3-4, p. 73
The traffic in narcotics, No. 1, p. 1
Treatment of drug addicts, No. 2, p. 18
Conventions
The traffic in narcotics, No. 1, pp. 1, 2, 3
Costa Rica
1953 Protocol, No. 2, p. 69
Cotarnine
Physical data, No. 1, p. 12
X-ray diffraction, No. 2, pp. 31, 38, 40, 42, 43, 45, 48 (fig. No. 12, p. 61)
Cryptopine
Physical data, No. 1, p. 12
X-ray diffraction data, No. 2, p. 48 (fig. No. 13)
Curves
Spectral data, pp. 21, 27 et seq., 34, 35, 36, 43, 44, 50-63
Czechoslovakia
Use of heroin discontinued, No. 1, p. 42
Demerol, Dolosal, see: Pethidine
Denmark
1953 Protocol, No. 2, p. 69, 70
Desclaux, P., Derobert, L., Katz, R.F.
Aspect d'actualité des toxicomanies, No. 2, pp. 10, 13, 14
Dextrorphan, dextromethorphan hydrobromide
Expert Committee (WHO), No. 1, p. 46
Physical data, No. 1, p. 14
Diamorphine, diacetylmorphine, see: Heroin
Dihydrocodeine, dihydrocodeinone, bitartrate
X-ray diffraction data, No. 2, p. 48, 49 (fig. Nos. 16, 17, 18, p. 61)
Dihydromorphine
Nonaqueous titration, No. 1, p. 21
X-ray diffraction data, No. 2, p. 49 (fig. No. 19, p. 61)
Dihydromorphinone
Identification (X-ray diffraction), No. 2, p. 32, 33, 38, 40, 42, 43 et seq. (fig. No. 20, p. 61)
X-ray diffraction data, No. 2, p. 49
Dihydrooxycodeinone (Eucodal, Eubine, Pancodine)
Drug addiction in France, No. 2, p. 9
Dioxyline
Physical data, No. 1, p. 13
X-ray diffraction data, No. 2, p. 49 (fig. No. 21, p. 62)
Diseases of the poppy plant, No. 3-4, p. 9, 10
Dithienylbutenylamines
Bibliography, No. 1, pp. 55, 56; No. 3-4, p. 87
Expert Committee (WHO), No. 1, p. 46
Dominican Republic
1953 Protocol, No. 2, p. 69
Drug Supervisory Body
Estimates of World Requirements of Narcotic Drugs, No. 3-4, p. 72
East India Company
Opium trade, No. 3-4, p. 1
Ecgonine
Physical data, No. 1, p. 17
Economic and Social Council
Eighteenth session, No. 3-4, pp. 71-75
Ecuador
1953 Protocol, No. 2, p. 69
Egypt
Committee on seizures, No. 3-4, p. 72 1953 Protocol, No. 2, p. 69, 70
Ethiopia
Use of heroin discontinued, No. 1, p. 42
Ethyhmorphine
Conversion into morphine, No. 1, p. 44
Ethylmorphine hydrochloride
X-ray diffraction data, No. 2, pp. 38 et seq.,(fig. No. 22, p. 62)
Ethylnarceine hydrochloride
X-ray diffraction data, No. 2, pp. 49, 50 (fig. No. 23, p. 62)
Ethylpethidine hydrochloride
Physical data, No. 1, p. 16 X-ray diffraction data, No. 2, p. 50 (fig. No. 24, p. 62)
Eucodal, see Dihydrooxycodeinone
Expert Committee on Drugs liable to produce Addiction
International non-proprietary names, No. 1, p. 46; list of. No. 1, p. 47
Report (4th session), No. 1, pp. 44-47
Exports
Coca leaves, No. 1, p. 40 Opium, No. 1, p. 40
Farmilo, Charles G.
Comments on scientific research, No. 3-4, pp. 72, 73
Physical methods for the identification of narcotics, Part I B, No. 1, pp. 7-19; Part III A, No. 3, pp. 18-41; Part III B, No. 3, pp. 42, 70
Finland
Heroin consumption, No. 1, p. 42
France
Heroin production, No. 1, p. 41 Indian hemp
Legislation in Tunisia, No. 2, pp. 71-72 Morphine production, No. 1, p. 40 Opium monopolies, No. 1, p. 2 1953 Protocol, No. 2, pp. 69, 70 The traffic in narcotics, No. 1, p. 1
Gassner, S. see: Grosfeld-Nir, I.
Germany, Federal Republic of Commission on Narcotics Drugs (9th session), No. 3-4, p. 71
Heroin, Abolish use of, No. 1, p. 42 Heroin production, No. 1, p. 41 Morphine production, No. 1, p. 40 1953 Protocol, No. 2, p. 69
Ginsburg, David
The application of conformational analysis to morphine derivatives, No. 1, pp. 32-38
Goldstein, N. L.
Drug addiction. Treatment, care and rehabilitation, No. 2, pp. 18-20
Gourion, Dr.
Drug addiction in France, No. 2, pp. 10, 11Greece
Committee of Chemical Experts, No. 3-4, pp. 72, 73
Committee on Seizures, No. 3-4, p. 721948 Protocol and 1953 Protocol, No. 2, p. 69
Grosfeld-Nir, I., Gassner, S. and Weissenberg, E. A quantitative method for the isolation and determination of morphine in opium and medicinal preparations, No. 2, pp. 23-26
Hanswalt Index
X-ray diffraction (Identification), No. 2, pp. 41-68
Hashish see: Cannabis sativa
Hayat, J. F.
Morphinomanes et morphiniques, No. 2, pp. 13, 14
Heroin (diacetylmorphine, diamorphine)
Abolition of use, No. 1, pp. 41, 42 Bibliography, No. 1, pp. 51, 52 Commission on Narcotics Drugs (9th session), No. 3-4, pp. 71, 72, 74
Consumption, No. 1, p. 42 Drug addiction in France, No. 2, pp. 1 et seq.Heroin in the USA, No. 1, p. 3 Manufacture, No. 1, p. 41 Teenagers, No. 1, p. 5 WHO (6th Assembly), No. 1, p. 45 X-ray Diffraction, No. 2, pp. 31, 32, 38, 40, 42, 43, 44, 48 (fig. Nos. 14, 15, p. 61)
Hungary
Heroin production, No. 1, p. 41 Morphine production, No. 1, p. 40
Hydrastinine, hydrochloride monohydrate
X-ray diffraction data, No. 2, p. 50 (fig. No. 25, p. 62)
Hydrocodone bitartrate
Physical data, No. 1, p. 12
Hydromorphone, hydrochloride
Physical data, No. 1, p. 15
Hydroxypethidine hydrochloride
Physical data, No. 1, p. 16 X-ray diffraction data, No. 2, p. 50 (figs. Nos. 26, 27, p. 62)
Iceland
Use of heroin discontinued, No. 1, p. 42 Identification
Physical methods for the identification of narcotics, Part I B, No. 1, pp. 7-19; Part II A, No. 1, pp. 20-31
Spectrophotometric, No. 3, p. 26
Tables
Absorption maxima, by wave-lengths, No. 3-4, p. 46; chemical families, pp. 64-66 Csoskan, No. 3-4, p. 32 Formula index, No. 3-4, pp. 68-69 Morgan, No. 3-4, p. 33 Name index, No. 3-4, pp. 67-69
Illicit traffic
Commission on Narcotic Drugs (9th session), No. 3-4, pp. 71-72
Pakistan, No. 3-4, p. 15
PCOB Report (1953), No. 1, pp. 42-43
The traffic in narcotics, No. 1, pp. 1-6
Index of narcotics
Alphabetical (X-ray diffraction data), No. 2, pp. 38-39
Figures (X-ray diffraction), No. 2, pp. 59-68 Innermost line, No. 2, p. 40
Numerical (Hanawalt), No. 2, pp. 40-46 Tabulated (d, I/Ii) data, No. 2, pp. 46-58
India
Committee on Seizures, No. 3-4, p. 72 Cultivation of opium poppy in India, No. 3-4, pp. 1-10
Export of opium, No. 1, p. 40 1953 Protocol, No. 2, pp. 69, 70 Raw opium production, No. 1, p. 39
Indian hemp see: Cannabis sativa
Indonesia
Coca leaves, No. 1, p. 40Use of heroin discontinued, No. 1, p. 42
Instruments
Beckman spectrophotometer, No. 3-4, pp. 23, 24 (ill.), 25
Spectrophotometer, No. 3-4, p. 20 (ill.) Spekker photometer, No. 3-4, p. 22 (ill.)
Internal Revenue, USA
Control of narcotics, No. 1, pp. 2, 3
International Confederation of Free Trade Unions
Commission on Narcotic Drugs (9th session), No. 3-4, p. 71
International Conference of Catholic Charities Commission on Narcotic Drugs (9th session), No. 3-4, p. 71
International Criminal Police Commission Commission on Narcotic Drugs (9th session), No. 3-4, p. 71
International Federation of Women Lawyers Commission on Narcotic Drugs (9th session), No. 3-4, p. 71
Illicit traffic, No. 3-4, p. 72
Iran
Export of opium, No. 1, p. 40 1953 Protocol, No. 2, p. 69 Raw opium production, No. 1, p. 39 Use of heroin discontinued, No. 1, p. 42
Iraq
1953 Protocol, No. 2, p. 69
Ireland
1948 Protocol, No. 2, p. 69
Isomethadone, dl-, hydrochloride Physical data, No. 1, p. 13 X-ray diffraction data, No. 2, p. 50 (fig. No. 28, p. 62)
Israel
1953 Protocol, No. 2, p. 69
Italy
Commission on Narcotic Drugs (9th session), No. 3-4, p. 71
Heroin consumption, No. 1, p. 42 Heroin production, No. 1, p. 41 Illicit traffic, No. 3-4, p. 72 Morphine production, No. 1, p. 40 1953 Protocol, No. 2, p. 69
Japan
Commission on Narcotic Drugs (9th session), No 3-4, p. 71.
Morphine production, No. 1, p. 40
Japan ( continued)
Occupied territories, No. 1, p. 2
1953 Protocol, No. 2, pp. 69, 70
Jordan
Use of heroin discontinued, No. 1, p. 42
Josie, Gordon H.
A report on drug addiction in Canada, No. 2, p. 7-9
Juvenile delinquency
Traffic in narcotics, No. 1, p. 5
Ketobemidone hydrochloride
Physical data, No. 1, p. 16
X-ray diffraction data, No. 2, pp. 50, 51 (figs. Nos. 29, 30, p. 62)
Kif see: Cannabis sativa
Korea, Republic of
1953 Protocol, No. 2, p. 70
Krishnamoorthy, E. S.
Commission on Narcotic Drugs (9th session), No. 3-4, p. 71
Laos and Vietnam
Commission on Narcotic Drugs (9th session), No. 3-4, p. 71
Non-medical consumption, No. 1, p. 40
Raw opium production, No. 1, p. 39
Use of heroin discontinued (Laos), No. 1, p. 42
Laudanine, dl-
Physical data, No. 1, p. 14
X-ray diffraction data, No. 2, p. 51 (fig. No. 31 p. 63)
Laudanum
Drug addiction in France, No. 2, p. 9
Laws (Legislation)
National legislations (1952), No. 2, pp. 69-72
Synthetic drugs, No. 1, p. 44
League of Nations
Advisory Committee
Morphine production, No. 1, p. 42
Traffic in narcotics, No. 1, pp. 1-6
Supervisory Body
Traffic in narcotics, No. 1, p. 1
Lebanon
Commission on Narcotic Drugs (9th session), No. 3-4, p. 71
1953 Protocol, No. 2, p. 69
Legal trade in 1952, No. 1, pp. 39-43
Le Guillant
Les toxicomanies, No. 2, p. 14
Leriche, Professor
La chirurgie de la douleur, No. 2, p. 12
Levi, Leo
Physical methods for the identification of narcotics, Part I B, No. 1, pp. 7-19; Part III B, No. 3-4, pp. 42-70
Levorphan tartrate
Physical data, No. 1, p. 14
Lexington Hospital
Treatment of addicts, No. 1, p. 6; No. 2, p. 17
Liang, Dr.
Comments on scientific research, No. 3-4, p. 72, 73
Liechtenstein
1953 Protocol, No. 2, p. 69
Luxembourg
1948 Protocol, No. 2, p. 69
Meyran García, S. see : Sodi Pallares, E.
Marihuana see: Cannabis sativa
Mayoral Pardo, Prof. D.
Drug addiction. Some aspects of the social medical problem as seen by the general practitioner, No. 2, pp. 21-22
Meconic acid
Meconic acid trihydrate, X-ray diffraction data, No. 2, p. 51 (fig. No. 32, p. 63)
Physical data, No. 1, p. 17
Mescaline
Bibliography, No. 1, p. 57
Identification (X-ray diffraction), No. 2, pp. 33, 39, 40 et seq. (fig., p. 63)
Mescaline sulfate, Physical data, No. 1, p. 15
Mescaline sulfate dihydrate, X-ray diffraction data, No. 2, p. 51
Methadone
Addiction treatment, No. 1, p. 4
Bibliography, No. 1, p. 55; No. 3-4, pp. 77-83
Methadone, d-,dl-methadone, l-methadone hydrobromide, hydrochloride, Physical data, No. 1, p. 12
Expert Committee (WHO), also on metha-done-like substances, No. 1, p. 45, 46
Identification (X-ray diffraction), No. 2, p. 33, 39, 40, 42 et seq. (figs. Nos. 34, 35, 36, 37, p. 63)
Methods
Quantative method re: morphine, No. 2, pp. 23-26
Ultraviolet spectrophotometric method, No. 3-4, p. 18-41; Review No. 3-4, p. 26-34
X-ray diffraction, No. 2, pp. 27-68
Methorphan, dl- dl-Methorphan, d- and l-, hydrobromide monohydrate, dihydrate
X-ray diffraction data, No. 2, p. 52 (figs. Nos. 38, 39, 40, p. 63)
Methopon hydrochloride
Identification (X-ray diffraction), No. 2, pp. 34, 39, 40 et seq. (fig., p. 64)
Physical data, No. 1, p. 15
X-ray diffraction data, No. 2, pp. 52, 53 (figs. Nos. 43, 44, p. 46)
Methylketobemidone hydrochloride
Physical data, No. 1, p. 16
X-ray diffraction data, No. 2, p. 52 (figs. Nos. 41, 42, p. 64)
6-methyl- Δ 6 e-desoxymorphine
Expert Committee (WHO), No. 1, p. 45
Mexico
Adulteration of Mexican opium, No. 3-4, p. 16-17
Monaco
1953 Protocol, No. 2, p. 69
Monoacetylmorphine, α-
X-ray diffraction data, No. 2, p. 53 (fig. No. 45, p. 64)
Monopolies
Opium monopoly in India, No. 3-4, p. 1
Opium production, No. 1, p. 39
United States, No. 1, p. 2
Morphinan
Bibliography, No. 1, p. 55, No. 3-4, pp. 84-87
Physical data, No. 1, p. 13
Substances of morphinan type, No. 1, p. 46
Morphine
A quantitative method for the isolation and determination of morphine in opium and medicinal preparations, No. 2, pp. 23-26
Application of conformational analysis to morphine derivatives, No. 1, pp. 32-38
Bibliography, No. 1, pp. 50, 51; No. 3-4, pp. 84-87 (morph. synthesis)
Characterization from structure, No. 1, p. 44
Content in Indian opium, No. 3-4, pp. 5, 8, 9,10
Conversion of codeine, ethylmorphine, No. 1, p. 44
Drug addiction in France, No. 2, pp. 1 et seq.
Identification (X-ray diffraction), No. 2, pp. 34, 39, 40 et seq. (fig., pp. 64-65) in the U.S.A., No. 1, p. 3
Manufacture, No. 1, pp. 40, 41, 42
Manufactured from poppy straw, No. 1, p. 40
Physical data, No. 1, pp. 14, 15 (dihydro, ethyl, α-monoacetyl, etc.)
Retard preparations, No. 1, pp. 44, 45
X-ray diffraction data, No. 2, pp. 53, 54: (figs. Nos. 46-53, pp. 64, 65)
Morphinone
Physical data, No. 1, p. 15
Morphothebaine hydrochloride
Physical data, No. 1, p. 15
X-ray diffraction data, No. 2, p. 54 (fig. No. 54, p. 65)
N-allylnormorphine (Nalorphine), diacetyl-N-allylnormorphine hydrochloride
Expert Committee (WHO), No. 1, p. 45
Physical data, No. 1, p. 15
X-ray diffraction data, No. 2, pp. 54, 55 (fig. No. 5, p. 65)
Narceine
Physical data, No. 1, p. 15
X-ray diffraction data, No. 2, p. 55 (fig. No. 56, p. 65)
Narcotine, hydrochloride
Content in Indian Opium, No. 3-4, p. 8, 9
Identification (X-ray diffraction), No. 2, p. 35, 39, 40, 41 et seq. (figs., Nos. 57-60, p. 65)
Physical data, No. 1, p. 15
National Research Council, U.S.A.
Drug addiction, No. 1, p. 44
Neopine hydrobromide
Physical data, No. 1, p. 15
X-ray diffraction data, No. 2, p. 55 (fig. No. 61, p. 66)
Netherlands
Opium monopolies, No. 1, p. 2
1953 Protocol, No. 2, p. 69
The traffic in narcotics, No. 1, p. 1
New Zealand
Heroin consumption, No. 1, p. 42
1953 Protocol, No. 2, p. 70
Nomenclature
International non-proprietary names, No. 1, p. 46 (WHO)
- Listed by Expert Committee (WHO), No. 1, p. 47
- Non-proprietary, trade and chemical names, No. 1, pp. 17-19
Oestreicher, Pamela M.
Physical methods for the identification of narcotics, Part I B, No. 1, pp. 7-19;Part III B, No. 3-4, pp. 42-70
Opianic acid
X-ray diffraction data, No. 2, pp. 55, 56 (fig. No. 62, p. 66)
Opium
Adulteration of Mexican opium, No. 3-4, pp. 16-17
Bibliography, No. 1, p. 50
Morphine content, No. 2, pp. 23-26
Opium in Pakistan, No. 3-4, pp. 11-15
Raw opium production, No. 1, p. 39
Research on origin, No. 3-4, pp. 72, 73
Traffic in narcotics, No 1, pp. 1-6
Opium poppy
Bibliography, No. 1, p. 50
Cultivation of the opium poppy in India, No. 3-4, pp. 1-10
Opium-smoking
Drug addiction in France, No. 2, p. 9
Illegal, No. 1, p. 2
Pakistan, No. 3-4, p. 13
Orphan hydrobromide, dl-, d- and l- tartrate dihydrate
X-ray diffraction data, No. 2, p. 56 (figs. Nos. 63, 64, 65, p. 66)
Oxycodone hydrochloride
Physical data, No. 1, p. 12
X-ray diffraction data, No. 2, p. 56 (fig. No. 66, p. 66)
Pakistan
Map, No. 3-4, p. 14
Opium imports, No. 1, p. 40
Opium in Pakistan, No. 3-4, pp. 11-15
1948 Protocol, No. 2, p. 69
1953 Protocol, No. 2, p. 70
Panama
1953 Protocol, No. 2, p. 70
Use of heroin discontinued, No. 1, p. 42
Panopoulos, Dr.
Comments on scientific research, No. 3-4, pp. 72, 73
Papaver
Species and varieties, No. 3-4, pp. 2, 3, 4, 5 (ill.)
Papaverine hydrochloride
Physical data, No. 1, pp. 13, 14
X-ray diffraction data, No. 2, pp. 56, 57 (figs. Nos. 68, 69, p. 66)
X-ray diffraction powder patterns, No. 1, p. 28
Pax Romana
Commission on Narcotics Drugs (9th session), No. 3-4, p. 71
Penalties
Traffic in narcotics, No. 1, pp. 2, 3, 4, 5
Permanent Central Opium Board
1953 Report, No. 1, pp. 39-43; No. 3-4, pp. 72-75
Peru
Coca leaves, No. 1, p. 40
Pests of the poppy plant, No. 3-4, pp. 9, 10
Pethidine (Dolosal, Demerol) hydrochloride
Bibliography, No. 1, pp. 54, 55
Drug addiction in France, No. 2, p. 9
Identification, No. 2, pp. 36, 39, 40, 42 et seq. (fig. No. 71, p. 67 (X-ray diffraction))
Physical data, No. 1, p. 16
X-ray diffraction data, No. 2, p. 57
Phanadoxone, hydrochloride
Physical data, No. 1, p. 13
X-ray diffraction data, No. 1, p. 57 (figs. Nos. 72, 73, p. 67)
Philippines
1953 Protocol, No. 2, p. 70
Physical data, names and formulas
- tabulated, No. 1, pp. 12-17
Physicians
Control of narcotics, No. 1, pp. 2, 3
Piperidine
Physical data, No. 1, p. 15
Pipidone hydrochloride
Physical data, No. 1, p. 13
X-ray diffraction data, No. 2, p. 57 (fig. No. 74, p. 67)
Poland
Comments on illicit traffic, No. 3-4, p. 72
Poppy straw
Manufacture of morphine, No. 1, p. 40 Portugal
Opium monopolies, No. 1, p. 2
Prodine, alpha, beta, dl-, hydrochloride
Identification (X-ray diffraction), No. 2, pp. 36, 39, 40, 42 et seq. (fig., pp. 67, 68)
Physical data, No. 1, p. 15
X-ray diffraction data, No. 2, pp. 57, 58 (figs. Nos. 75, 76, p. 67)
Propylketobemidone
X-ray diffraction data, No. 2, p. 58 (fig. No. 77, p. 67)
Protocol, 1948
Accepted by various countries, No. 2, p. 69
Synthetic drugs control, No. 1, pp. 42, 43
Protocol, 1953
Commission on Narcotic Drugs (9th session), No. 3-4, p. 73
Ratified, No. 2, p. 70
Signed by various countries, No. 2, pp. 69, 70
Protopine
Identification (X-ray diffraction), No. 2, pp. 36, 40, 43 et seq. (fig. No. 78, p. 67)
Physical data, No. 1, p. 16
Pseudomorphine trihydrate
Physical data, No. 1, p. 16
X-ray diffraction data, No. 2, p. 58 (fig. No. 79, p. 67)
Pyrahexyl
Physical data, No. 1, p. 17
Quasi-medical use
Pakistan, No. 3-4, p. 11
Racemethorpan hydrobromide
Physical data, No. 1, p. 14
Racemorphan hydrobromide
Physical data, No. 1, p. 14
Raw materials
New single convention, No. 1, p. 2
Raw Opium
see: Opium
Report
Annual reports, No. 34, p. 71
Commission on Narcotic Drugs to ECOSOC, No. 3-4, pp. 71 et seq. on narcotic clinics, No. 2, p. 19
Permanent Central Opium Board, No. 1, pp. 39-43, No. 3-4, pp. 72-75
Resolutions
ECOSOC on synthetic drugs, No. 1, p. 44 436 (XIV) G (ECOSOC), No. 1, p. 45
Russell Pasha (Sir Thomas Wentworth)
Obituary, No. 3-4, p. 76
Saudi Arabia
Use of heroin discontinued, No. 1, p. 42
Sheppard, Helen M.
Physical methods for the identification of narcotics, Part II B, No. 2, pp. 27-68
Sinomenine
Physical data, No. 1, p. 17
X-ray diffraction data, No. 2, p. 58 (fig. No. 80, p. 67)
Sodi Pallares, E.; S. Meyran García
Adulteration of Mexican opium, No. 3-4, pp. 16-17
South Korea
Use of heroin discontinued, No. 1, p. 42
Spain
1953 Protocol, No. 2, p. 70
Spectra
Absorption curves, tables, No. 3-4, pp. 28, 29 et seq.
Influence of pH, tables, No. 3-4, pp. 36, 37, 38, 39
Quantitative spectrometry, No. 3-4, p. 34
Ultraviolet spectral data for ninety narcotics and related compounds, No. 3-4, pp. 42-70
Ultraviolet spectrophotometric method, No. 3-4, pp. 18-41
Statistics
Drug addiction in France, No. 2, pp . 1-17; in Canada, No. 2, pp. 7-9
Stern, G.; Ch. Vaille
Drug addiction, medical and social aspects in France, No. 2, pp. 1-17
Supervisory Body
Question of heroin, No. 1, pp. 41-42
Sweden
Heroin, Abolish use of, No. 1, p. 42 consumption, No. 1, p. 42 production, No. 1, p. 41
Switzerland
Commission on Narcotic Drugs (9th session), No. 3-4, p. 71
Dexrorphan and dextromethorphan, No. 1, p. 46
Morphine production, No. 1, p. 40
1948 Protocol, No. 2, p. 69
1953 Protocol, No. 2, p. 70
The traffic in narcotics, No. 1, p. 1
Synthetic drugs
Bibliography, No. 1, pp. 54-56; No. 2, pp. 73-83
Commission on Narcotic Drugs (9th session), No. 3-4, p. 74
Expert Committee (WHO), No. 1, pp. 44, 45, 46
Illicit traffic, No. 3-4, p. 72
Synthetic drugs ( continued)
Legislation in 1952, No. 2, pp. 69-72
New single convention, No. 1, p. 2
1948 Protocol, No. 1, pp. 42, 43
Tables
Absorbency (Morgan), No. 3-4, p. 33
Absorption maxima, minima (Elvidge), No 3-4, p. 37
Absorption, by wave-lengths, No. 3-4, p. 46
Beckman spectrophotometer, No. 3-4, p. 25
Effect of pH on absorption maxima, No. 3-4, p. 37
Formula index for spectra, No. 3-4, pp. 68-69
Key-points in absorption spectra (Edwards), No. 3-4, p. 39
Name index for ultra-violet spectra, No. 3-4, pp. 67-68
Relation of concentration to absorbency, No. 3-4, p. 39
Spectral data, by chemical families, No. 3-4, pp. 64-66
Spectrophotometric data (Csoskan), No. 3-4 p. 32
Takrouri see: Cannabis sativa
Thailand
Commission on Narcotic Drugs (9th session), No.3-4, p. 71
Non-medical consumption, No. 1, p. 40
Opium-smoking, No. 1, p. 2
Use of heroin discontinued, No. 1, p. 42
Thebaine hydrochloride
Physical data, No. 1, p. 17
X-ray diffraction data, No. 2, p. 58 (figs. Nos. 81, 82, p. 68)
Thebenine, hydrochloride monohydrate
Identification (X-ray diffraction), No. 2, pp. 37, 39, 40, 42 et seq. (fig. No. 83, p. 68)
Physical data, No. 1, p. 17
Tompkins, W. F.
The traffic in narcotics, No. 1, pp. 1-6 (photo)
Treaties, Conventions
The traffic in narcotics, No. 1, pp. 1-6
Trichocereine hydrochloride
Physical data, No. 1, p. 15
Turkey
Committee on Seizures, No. 3-4, p. 72
1953 Protocol, No. 2, p. 70
Raw opium production, No. 1, p. 39
Use of heroin discontinued, No. 1, p. 42
Ultraviolet
Absorption spectrophotometry (review), No. 3-4, pp. 26-34
Influence of pH, No. 3-4, pp. 36, 37, 38
Quantitative spectrophotometry, No. 3-4, pp. 34, 35, 36
Spectral data for 90 narcotics and related compounds, No. 3-4, pp. 42-70
Union of South Africa
Commission on Narcotic Drugs (9th session), No. 3-4, p. 71
1953 Protocol, No. 2, p. 70
Use of heroin discontinued, No. 1, p. 42
Union of Soviet Socialist Republics
Convention, Illicit Traffic, No. 3-4, p. 72
Morphine production, No. 1, p. 40
Raw opium production, No. 1, p. 39
Use of heroin discontinued, No. 1, p. 42
United Kingdom
Committee on Seizures, No. 3-4, p. 72
Heroin consumption, No. 1, p. 42
Heroin production, No. 1, p. 41
Morphine production, No. 1, p. 40
Opium monopolies, No. 1, p. 2
1953 Protocol, No. 2, p. 70
United States of America
Committee on Seizures, No. 3-4, p. 72
Control of narcotics, No. 1, p. 2
Dithienylbutenylamines, No. 1, p. 46
Legislation on addiction, No. 2, pp. 70-71
Methadone-like substances, No. 1, pp. 45, 46
Morphinan-type substances, No. l, p. 46
N-allylnormorphine, No. 1, p. 45; 6-methyldesoxymorphine and diacetyl-N-allylnormorphine, No. 1, p 45
1953 Protocol, No. 2, p. 70
The traffic in narcotics, No. 1, pp. 1-6;No. 3-4, p. 72
Treatment of addicts, No. 2, pp. 18 et seq.
Vaille, C.
Drug addiction, Medical and social aspects in France, No. 2, pp. 1-17
Commission on Narcotic Drugs (9th session), No. 3-4, p. 71
Venezuela
1953 Protocol, No. 2, p. 70
Viet-Nam
Commission on Narcotic Drugs (9th session,) No. 3-4, p. 71
1953 Protocol, No. 2, p. 70
Vogel, Dr. V. H.
Drug addiction in France, No. 2, pp. 16, 17
Weissenberg, E. see: Grosfeld-Nir, I.
WHO
Question of heroin, No. 1, pp. 41-42
Withdrawal
Methadone, No. 1, p. 4
Treatment of drug addicts, No. 1, p. 18
Wolff, P. O.
Eumorphine, No. 2, p. 22
Quelques aspects actuels de la toxicomanie, No. 2, p. 15
World Federation of Trade Unions
Commission on Narcotic Drugs (9th session), No. 3-4, p. 71
World Health Organization (WHO)
Commission on Narcotic Drugs, No. 3-4, p. 71
Drug addiction, No. 3-4, pp. 73, 74
Report, No. 3-4, p. 72
World Union for Progressive Judaism
Commission on Narcotic Drugs (9th session), No. 3-4, p. 71
World's Alliance of YMCA
Commission on Narcotic Drugs (9th session), No. 3-4, p. 71
Wright, A. E.
Opium in Pakistan, No. 3-4, pp. 11-15
The X-Ray diffraction powder method
Data, No. 2, pp. 27-68
Identification of narcotics, No. 1, pp. 20-31
Yield
Morphine, codeine, narcotine in Indian poppies, No. 3, pp. 8, 9, 10
Opium in poppies (India), No. 3-4, pp. 2, 3
Opium (Pakistan), No. 3-4, pp. 12, 13
Yugoslavia
Morphine production, No. 1, p. 40
1952 Protocol, No. 2, p. 70
Raw opium production, No. 1, p. 39
The traffic in narcotics, No. 1, p. 1
Use of heroin discontinued, No. 1, p. 42